SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-21-000130
Filing Date
2021-11-09
Accepted
2021-11-09 17:06:09
Documents
66
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20210930.htm   iXBRL 10-Q 1727685
2 EX-31.1 lgnd_93021exhibit311.htm EX-31.1 15168
3 EX-31.2 lgnd_93021exhibit312.htm EX-31.2 15401
4 EX-32.1 lgnd_93021exhibit321.htm EX-32.1 11359
10 lgnd-20210930_g1.jpg GRAPHIC 51754
  Complete submission text file 0000886163-21-000130.txt   8587767

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20210930.xsd EX-101.SCH 51575
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20210930_cal.xml EX-101.CAL 102877
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20210930_def.xml EX-101.DEF 288200
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20210930_lab.xml EX-101.LAB 734090
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20210930_pre.xml EX-101.PRE 457081
11 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20210930_htm.xml XML 1572635
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 211393145
SIC: 2834 Pharmaceutical Preparations